The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 2, 2009, Pages 377-386

  Salustio P J ^a   Feio, G ^b,c   Figueirinhas, J L ^c   Pinto, J F ^a   Cabral Marques, H M ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c Centro de Fisica da Materia Condensada   (Portugal)

Author keywords

Cyclodextrin; DSC; Freeze drying; FT IR spectroscopy; Ibuprofen; Indomethacin; Kneading; NMR; Optical microscopy; Physical mixture; Spray drying; UV spectroscopy; X ray

Indexed keywords

BETA CYCLODEXTRIN; IBUPROFEN; INDOMETACIN;

ACIDITY; AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; FREEZE DRYING; INFRARED SPECTROSCOPY; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE; PH; POWDER; SPRAY DRYING; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; FREEZE DRYING; HYDROGEN-ION CONCENTRATION; IBUPROFEN; INDOMETHACIN; POWDERS; SOLUBILITY;

EID: 59649105647     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.09.027     Document Type: Article

References (38)

1. Charoenchaitrakool M., Dehghani F., and Foster N.R. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin. Int. J. Pharm. 239 (2002) 103-112
2. Loftsson T., Hreinsdóttir D., and Másson M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302 (2005) 18-28
3. Loftsson T., and Duchêne D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329 (2007) 1-11
4. Pose-Vilarnovo B., Rodriguez-Tenreiro C., Santos J.F., Vásquez-Doval J., Concheiro A., Alvarez-Lorenzo C., and Torres-Labandeira J. Modulating drug release with cyclodextrins in hydroxypropyl methycellulose gels and tablets. J. Control. Release 94 (2004) 351-363
5. 1H NMR and molecular modeling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in presence of malic acid. J. Pharm. Biomed. Anal. 23 (2000) 25-31
6. Loftsson T., Másson M., and Brewster M.E. Self-association of cyclodextrins and cyclodextrins complexes. J. Pharm. Sci. 93 (2004) 1091-1099
7. Loftsson T., Össurardóttir I.B., Duan M., Zhao N., Thorsteinsson T., and Másson M. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: effect of ionization and polymers. J. Incl. Phenom. Macrocycl. Chem. 52 (2005) 109-117
8. Duan M., Zhao N., Össurardóttir I.B., Thorsteinsson T., and Loftsson T. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes. Int. J. Pharm. 297 (2005) 213-222
9. Loftsson T., Hreinsdóttir D., and Másson M. The complexation efficiency. J. Incl. Phenom. Macrocycl. Chem. 57 (2007) 545-552
10. 1H NMR studies on host-guest interaction of paeonol and two of its isomers with β-cyclodextrin. Int. J. Pharm. 316 (2006) 7-13
11. van Hees T., Piel G., Evrard B., Otte X., Thunus L., and Delattre L. Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound. Pharm. Res. 16 (1999) 1864-1870
12. Higgins J.D., Gilmor T.P., Martellucci S.A., Bruce R.D., and Brittain H.G. Ibuprofen. Analytical Profiles of Drug Substances vol. 27 (2001), Academic Press, London 265-300
13. Nerurkar J., Beach J.W., Park M.O., and Jun H.W. Solubility of (±)-ibuprofen and S (+)-ibuprofen in the presence of cosolvents and cyclodextrins. Pharm. Dev. Technol. 10 (2005) 413-421
14. Jambhekar S., Casella R., and Maher T. The physicochemical characteristics and bioavailability of indomethacin from β-cyclodextrin, hydroxyethyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 270 (2004) 149-166
15. O'Brien M., McCauley J., and Cohen E. Indomethacin. In: Florey K. (Ed). Analytical Profiles of Drug Substances vol. 13 (1984), Academic Press Inc., San Diego 211-238
16. Wu C.-Y., and Benet L.Z. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22 (2005) 11-23
17. Miller L.A., Carrier R.L., and Ahmed I. Practical considerations in development of solid dosage forms that contain cyclodextrin. J. Pharm. Sci. 96 (2007) 1691-1707
18. Higuchi T., and Connors K.A. Phase solubility technique. Adv. Anal. Chem. Instrum. 4 (1965) 117-212
19. Lu W.L., Zhang Q., Zheng L., Wang H., Li R.Y., Zhang L.F., Shen W.B., and Tu X.D. Antipyretic analgesic and anti-inflammatory activities of ketoprofen β-cyclodextrin inclusion complex in animals. Biol. Pharm. Bull. 27 (2004) 1515-1520
20. Wulff M., and Aldén M. Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur. J. Pharm. Sci. 8 (1999) 269-281
21. Salvatierra D., Jaime C., Virgil A., and Sánchez-Ferrando F. Determination of the inclusion geometry for the β-cyclodextrin/benzoic acid complex by NMR molecular modeling. J. Org. Chem. 61 (1996) 9578-9581
22. European Pharmacopeia 6.0, 6th ed., vol. 1, edqm, Council of Europe, European Department for the Quality Medicine, Brussels, 2008, pp. 508-511.
23. Ghorab M.K., and Adeyeye M.C. Enhanced bioavailability of process-induced fast-dissolving ibuprofen cogranulated with β-cyclodextrin. J. Pharm. Sci. 92 (2003) 1690-1697
24. Gavira J.M., Hernanz A., and Bratu I. Dehydartion of β-cyclodextrin. An IR v (OH) band profile analysis. Vib. Spectrosc. 32 (2003) 137-146
25. Silverstein R.M., Bassler G.C., and Morrill T.C. Infrared spectrometry. Spectrometric Identification of Organic Compounds. 5th ed. (1991), John Wiley & Sons, Inc., New York 91-164
26. 1NMR studies. Pharm. Dev. Technol. 6 (2001) 315-324
27. Koester L.S., Xavier C.R., Mayorga P., and Bassani V.L. Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur. J. Pharm. Biopharm. 55 (2003) 85-91
28. Oh I., Lee M.-Y., Lee Y.-B., Shin S.-C., and Park I. Spectroscopic characterization of ibuprofen/2-hydroxypropyl-β-cyclodextrin inclusion complex. Int. J. Pharm. 175 (1998) 215-223
29. D. Bongiorno, L. Ceraulo, M. Ferrugia, F. Filizzola, A. Ruggirello, V. Turco, Inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin in solid phase, Arkat USA, inc., ISSN 1424-6376, Arkivoc XIV (2005) 118-130.
30. Tozuka Y., Fujito T., Moribe K., and Yamamoto K. Ibuprofen-cyclodextrin inclusion complex formation using supercritical carbon dioxide. J. Incl. Phenom. Macrocycl. Chem. 56 (2006) 33-37
31. Cassela R., Williams D.A., and Jambhekar S.S. Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. I. Formation studies. Int. J. Pharm. 165 (1998) 1-14
32. Waleczek K.J., Cabral Marques H.M., Hempel B., and Schmidt P.C. Phase solubility studies of pure (-)-α-bisabolol and camomile essential oil with β-cyclodextrin. Eur. J. Pharm. Biopharm. 55 (2003) 247-251
33. Scheneider H.J., Hacket F., and Rüdiger V. NMR studies of cyclodextrins and cyclodextrins complexes. Chem. Rev. 98 (1998) 1755-1785
34. 19F-NMR as a tool for investigation of drug-cyclodextrin complexes. Drug Dev. Ind. Pharm. 29 (2003) 107-112
35. Mura P., Bettinetti G.P., Manderioli A., Faucci M.T., Bramanti G., and Sorrenti M. Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state. Int. J. Pharm. 166 (1998) 189-203
36. Hussein K., Türk M., and Wahl M.A. Comparative evaluation of ibuprofen/cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods. Pharm. Res. 24 (2007) 585-592
37. Leite Pinto J.M.C., and Cabral Marques H.M. Anti-asthmatic-cyclodextrin inclusion complex for pulmonary delivery. STP-Pharma Sci. 9 (1999) 253-256
38. Fini A., Fernandez-Hervàs M.J., Holgado M.A., Rodriguez L., Cavallari C., Passerini N., and Caputo O. Fractal analysis of β-cyclodextrin-indomethacin particles compacted by ultrasound. J. Pharm. Sci. 86 (1997) 1303-1309